Balyasny Asset Management’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-432
| Closed | -$56K | – | 1437 |
|
|
2019
Q2 | $56K | Buy |
+432
| New | +$56K | ﹤0.01% | 1286 |
|
|
2019
Q1 | – | Sell |
-232
| Closed | -$44K | – | 1530 |
|
|
2018
Q4 | $44K | Sell |
232
-502
| -68% | -$95.2K | ﹤0.01% | 1238 |
|
|
2018
Q3 | $241K | Sell |
734
-201
| -21% | -$66K | ﹤0.01% | 1332 |
|
|
2018
Q2 | $292K | Buy |
935
+652
| +230% | +$204K | ﹤0.01% | 1350 |
|
|
2018
Q1 | $69K | Buy |
283
+45
| +19% | +$11K | ﹤0.01% | 1661 |
|
|
2017
Q4 | $72K | Buy |
+238
| New | +$72K | ﹤0.01% | 1752 |
|
|
2017
Q3 | – | Sell |
-8,237
| Closed | -$2.17M | – | 1840 |
|
|
2017
Q2 | $2.17M | Sell |
8,237
-18,380
| -69% | -$4.84M | 0.01% | 752 |
|
|
2017
Q1 | $9.58M | Buy |
26,617
+3,097
| +13% | +$1.11M | 0.04% | 447 |
|
|
2016
Q4 | $6.79M | Buy |
23,520
+7,489
| +47% | +$2.16M | 0.04% | 494 |
|
|
2016
Q3 | $5.46M | Buy |
+16,031
| New | +$5.46M | 0.03% | 479 |
|
|
2016
Q2 | – | Sell |
-252
| Closed | -$81K | – | 1243 |
|
|
2016
Q1 | $81K | Buy |
+252
| New | +$81K | ﹤0.01% | 1010 |
|
|
2015
Q4 | – | Sell |
-4,950
| Closed | -$1.45M | – | 1294 |
|
|
2015
Q3 | $1.45M | Buy |
+4,950
| New | +$1.45M | 0.01% | 547 |
|